These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36376143)

  • 1. Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries.
    Tsang CCS; Shih YT; Dong X; Garuccio J; Browning JA; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Zeng R; Wang J
    Value Health; 2023 May; 26(5):649-657. PubMed ID: 36376143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groups.
    Tsang CCS; Wang J; Shih YT
    Medicine (Baltimore); 2024 May; 103(18):e37935. PubMed ID: 38701304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
    Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
    Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
    Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
    Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
    Allen A; Hung A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
    Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
    J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.
    Spivey CA; Qiao Y; Wang J; Shih YT; Wan JY; Dagogo-Jack S; Cushman WC; Hines LE; Chisholm-Burns MA
    J Am Geriatr Soc; 2019 Mar; 67(3):581-587. PubMed ID: 30674080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
    Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.
    Lu D; Qiao Y; Johnson KC; Wang J
    J Asthma; 2017 Jun; 54(5):504-513. PubMed ID: 27676212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
    Wang J; Brown LM; Hong SH
    J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.
    Fox D; Ried LD; Klein GE; Myers W; Foli K
    J Am Pharm Assoc (2003); 2009; 49(2):192-9. PubMed ID: 19289345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.
    Qiao Y; Spivey CA; Wang J; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns MA
    Inquiry; 2018; 55():46958018795749. PubMed ID: 30175638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
    Welch EK; Delate T; Chester EA; Stubbings T
    Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
    Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.